ENYO Pharma Investors

17 investors on Angel Roster list ENYO Pharma in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in the United States, France and Germany.

Investors are matched on the company name in their portfolio, so companies that share the name ENYO Pharma can appear together.

Investors listed
17
With verified email
35%
Most common stage
Series B
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 17 ENYO Pharma investors

The most complete profiles first. Showing 17 of 17.

  • Jonathan LeffVerified

    Venture Capital, Investor · United States

    SeedSeries BHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 66 more

    Verified email available

  • Olivier LitzkaVerified

    Venture Capital, Private Equity Firm, Investor · Germany

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, Noxxon Pharma and 83 more

    Verified email available

  • Sarah BhagatVerified

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alan ColowickVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Jason PittsVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Mike PowellVerified

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Verified email available

  • Alexandre Foulon

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsDeepTech

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Arnaud Faure

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Carl Gordon

    Venture Capital

    SeedSeries AHealth and Hospital ServicesMedicalPharmaceuticals

    Portfolio: Good Start Genetics, Turning Point Therapeutics, Igenica, Odyssey Therapeutics and 18 more

    Contact details available

  • Maha Katabi, PhD, CFA

    Hedge Fund, Venture Capital, Investor · Canada

    SeedHealth CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 64 more

    Contact details available

  • Mayeul Caron

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Perry Nisen

    Venture Capital, Investor · United States

    SeedHealth CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Pierre

    Venture Capital, Private Equity Firm, Investor · France

    Series BHealth CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Alfred Yue

    Venture Capital · United States

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • David Robin

    Venture Capital, Private Equity Firm · France

    Health CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

  • Hooman Shahlavi

    Hedge Fund, Venture Capital · United States

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: ENYO Pharma, Y-mAbs Therapeutics, NuCana, Histogenics and 63 more

    Contact details available

  • Pierre Morisseau

    Venture Capital, Private Equity Firm · France

    Health CareWearablesHospitalsWellness

    Portfolio: Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma and 79 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many ENYO Pharma investors are on Angel Roster?

Angel Roster lists 17 ENYO Pharma investors. 6 of them (35%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (17), Private Equity Firms (7) and Hedge Funds (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do ENYO Pharma investors invest in?

Among those that list a stage, the most common are Series B (6), Seed (5) and Series A (1).

Where are ENYO Pharma investors based?

Most are based in the United States (8), France (6) and Germany (1).

Which companies have ENYO Pharma investors backed?

The most-backed portfolio companies among them are Athira Pharma (9), Medeor Therapeutics (9), InCarda Therapeutics (9), NorthSea Therapeutics (9) and Dauntless Pharmaceuticals (9).

How do I contact ENYO Pharma investors?

Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.